Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

11.1%

2 terminated out of 18 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

46%

6 of 13 completed with results

Key Signals

6 with results87% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (7)
P 1 (1)
P 2 (5)
P 3 (4)

Trial Status

Completed13
Terminated2
Suspended1
Enrolling By Invitation1
Recruiting1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07079774Recruiting

TrueLok Elevate PMCF Study

NCT01138436Phase 2CompletedPrimary

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers

NCT06702852Not ApplicableTerminatedPrimary

Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers

NCT06725797Not ApplicableEnrolling By InvitationPrimary

Study on the Effectiveness of Hypothermal Sulphurous Water in Wound Hygiene

NCT04274049Phase 3Completed

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

NCT04275323Phase 3Completed

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

NCT00701974Phase 2SuspendedPrimary

Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers

NCT00951080Not ApplicableCompletedPrimary

SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds

NCT00189540Phase 2Completed

Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

NCT00700154Not ApplicableTerminated

Insulin Infusion Diabetes Ulcer

NCT01548378Phase 2Completed

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

NCT00597818Phase 2Completed

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

NCT01439581Not ApplicableCompletedPrimary

Utility of Interface Pressure Mapping

NCT01942941Not ApplicableCompleted

Peripheral Vascular Disease and Nerve Stimulation

NCT01474109Phase 3Completed

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients

NCT01214811Phase 3Completed

Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

NCT00688428Phase 1CompletedPrimary

Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

NCT00718978Not ApplicableCompleted

Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)

Showing all 18 trials

Research Network

Activity Timeline